Preliminary study of anxiety symptoms, family dysfunction, and the brain-derived neurotrophic factor (BDNF) Val66Met genotype in offspring of parents with bipolar disorder

Journal of Psychiatric Research

Volumn 61, Issue , 2015, Pages 81-88

  Park, Min Hyeon ^a   Chang, Kiki D ^b   Hallmayer, Joachim ^b   Howe, Meghan E ^b   Kim, Eunjoo ^c   Hong, Seung Chul ^a   Singh, Manpreet K ^b  

^a The Catholic University of Korea   (South Korea)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Anxiety; Brain derived neurotrophic factor; Gene environment interaction; Pediatric bipolar; Risk

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; METHIONINE; VALINE;

ADOLESCENT; ALLELE; ANXIETY ASSESSMENT; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSFUNCTIONAL FAMILY; FAMILY ADAPTABILITY AND COHESION EVALUATION SCALE IV; FAMILY ASSESSMENT; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDIMENSIONAL ANXIETY SCALE FOR CHILDREN; PATHOGENESIS; PRIORITY JOURNAL; PROGENY; ADULT; CHILD; FAMILY; GENETIC PREDISPOSITION; GENETICS; PARENT; PSYCHOLOGY; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

ADOLESCENT; ADULT; ANXIETY DISORDERS; BIPOLAR DISORDER; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHILD; CHILD OF IMPAIRED PARENTS; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; PARENTS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; YOUNG ADULT;

EID: 84921545393     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2014.11.013     Document Type: Article

References (82)

1. Andreasen N.C., Endicott J., Spitzer R.L., Winokur G. The family history method using diagnostic criteria. Reliability and validity. Arch Gen Psychiatry 1977, 34:1229-1235.
2. Axelson D.A., Birmaher B., Strober M.A., Goldstein B.I., Ha W., Gill M.K., et al. Course of subthreshold bipolar disorder in youth: diagnostic progression from bipolar disorder not otherwise specified. JAm Acad Child Adolesc Psychiatry 2011, 50:1001 e3-1016 e3.
3. Baekken P.M., Skorpen F., Stordal E., Zwart J.A., Hagen K. Depression and anxiety in relation to catechol-O-methyltransferase Val158Met genotype in the general population: the Nord-Trøndelag Health Study (HUNT). BMC Psychiatry 2008, 8:48.
4. Baron R.M., Kenny D.A. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. JPers Soc Psychol 1986, 51:1173-1182.
5. Barron E., Sharma A., Le Couteur J., Rushton S., Close A., Kelly T., et al. Family environment of bipolar families: a UK study. JAffect Disord 2014, 152-154:522-525.
6. Bazak N., Kozlovsky N., Kaplan Z., Matar M., Golan H., Zohar J., et al. Pre-pubertal stress exposure affects adult behavioral response in association with changes in circulating corticosterone and brain-derived neurotrophic factor. Psychoneuroendocrinology 2009, 34:844-858.
7. Belardinelli C., Hatch J.P., Olvera R.L., Fonseca M., Caetano S.C., Nicoletti M., et al. Family environment patterns in families with bipolar children. JAffect Disord 2008, 107:299-305.
8. Bueller J.A., Aftab M., Sen S., Gomez-Hassan D., Burmeister M., Zubieta J.K. BDNF Val66Metallele is associated with reduced hippocampal volume in healthy subjects. Biol Psychiatry 2006, 59:812-815.
9. Carbone D.L., Handa R.J. Sex and stress hormone influences on the expression and activity of brain-derived neurotrophic factor. Neuroscience 2013, 239:295-303.
10. Chang K., Steiner H., Ketter T. Studies of offspring of parents with bipolar disorder. Am J Med Genet C Semin Med Genet 2003, 123C:26-35.
11. Chang K.D., Blasey C., Ketter T.A., Steiner H. Family environment of children and adolescents with bipolar parents. Bipolar Disord 2001, 3:73-78.
12. Chen Z.Y., Jing D., Bath K.G., Ieraci A., Khan T., Siao C.J., et al. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 2006, 314:140-143.
13. Colzato L.S., Van der Does A.J., Kouwenhoven C., Elzinga B.M., Hommel B. BDNF Val66Met polymorphism is associated with higher anticipatory cortisol stress response, anxiety, and alcohol consumption in healthy adults. Psychoneuroendocrinology 2011, 36:1562-1569.
14. Contreras J., Hare E., Pacheco A., Escamilla M., Raventos H. Is subclinical anxiety an endophenotype for bipolar I patients? A study from a Costa Rican sample. JAffect Disord 2010, 122:267-272.
15. Cunha A.B., Frey B.N., Andreazza A.C., Goi J.D., Rosa A.R., Gonçalves C.A., et al. Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neurosci Lett 2006, 398:215-219.
16. de Oliveira G.S., Ceresér K.M., Fernandes B.S., Kauer-Sant'Anna M., Fries G.R., Stertz L., et al. Decreased brain-derived neurotrophic factor in medicated and drug-free bipolar patients. JPsychiatr Res 2009, 43:1171-1174.
17. Dierker L.C., Merikangas K.R., Szatmari P. Influence of parental concordance for psychiatric disorders on psychopathology in offspring. JAm Acad Child Adolesc Psychiatry 1999, 38:280-288.
18. Duffy A., Horrocks J., Doucette S., Keown-Stoneman C., McCloskey S., Grof P. Childhood anxiety: an early predictor of mood disorders in offspring of bipolar parents. JAffect Disord 2013, 150:363-369.
19. Duman R.S. Synaptic plasticity and mood disorders. Mol Psychiatry 2002, 7(Suppl.1):S29-S34.
20. Dunham J.S., Deakin J.F., Miyajima F., Payton A., Toro C.T. Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains. JPsychiatr Res 2009, 43:1175-1184.
21. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003, 112:257-269.
22. Enoch M.A., White K.V., Waheed J., Goldman D. Neurophysiological and genetic distinctions between pure and comorbid anxiety disorders. Depress Anxiety 2008, 25:383-392.
23. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured clinical interview for DSM-IV axis I disorders - Patient edition (SCID-I/P, version 2.0) 1996, Biometrics Research Department, New York State Psychiatric Institute, New York.
24. Frodl T., Schüle C., Schmitt G., Born C., Baghai T., Zill P., et al. Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. Arch Gen Psychiatry 2007, 64:410-416.
25. Frustaci A., Pozzi G., Gianfagna F., Manzoli L., Boccia S. Meta-analysis of the brain-derived neurotrophic factor gene (BDNF) Val66Met polymorphism in anxiety disorders and anxiety-related personality traits. Neuropsychobiology 2008, 58:163-170.
26. Gatt J.M., Nemeroff C.B., Dobson-Stone C., Paul R.H., Bryant R.A., Schofield P.R., et al. Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety. Mol Psychiatry 2009, 14:681-695.
27. Geller B., Badner J.A., Tillman R., Christian S.L., Bolhofner K., Cook E.H. Linkage disequilibrium of the brain-derived neurotrophic factor Val66Met polymorphism in children with a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry 2004, 161:1698-1700.
28. Geller B., Zimerman B., Williams M., Bolhofner K., Craney J.L., DelBello M.P., et al. Reliability of the Washington University in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia (WASH-U-KSADS) mania and rapid cycling sections. JAm Acad Child Adolesc Psychiatry 2001, 40:450-455.
29. Gratacos M., Gonzalez J.R., Mercader J.M., de Cid R., Urretavizcaya M., Estivill X. Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biol Psychiatry 2007, 61:911-922.
30. Green E.K., Raybould R., Macgregor S., Hyde S., Young A.H., O'Donovan M.C., et al. Genetic variation of brain-derived neurotrophic factor (BDNF) in bipolar disorder: case-control study of over 3000 individuals from the UK. Br J Psychiatry 2006, 188:21-25.
31. Hünnerkopf R., Strobel A., Gutknecht L., Brocke B., Lesch K.P. Interaction between BDNF Val66Met and dopamine transporter gene variation influences anxiety-related traits. Neuropsychopharmacology 2007, 32:2552-2560.
32. Hariri A.R., Goldberg T.E., Mattay V.S., Kolachana B.S., Callicott J.H., Egan M.F., et al. Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. JNeurosci 2003, 23:6690-6694.
33. Hartmann M., Heumann R., Lessmann V. Synaptic secretion of BDNF after high-frequency stimulation of glutamatergic synapses. EMBO J 2001, 20:5887-5897.
34. Henin A., Biederman J., Mick E., Sachs G.S., Hirshfeld-Becker D.R., Siegel R.S., et al. Psychopathology in the offspring of parents with bipolar disorder: a controlled study. Biol Psychiatry 2005, 58:554-561.
35. Hofer M., Pagliusi S.R., Hohn A., Leibrock J., Barde Y.A. Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO J 1990, 9:2459-2464.
36. Holmbeck G.N. Toward terminological, conceptual, and statistical clarity in the study of mediators and moderators: examples from the child-clinical and pediatric psychology literatures. JConsult Clin Psychol 1997, 65:599-610.
37. Hong C.J., Huo S.J., Yen F.C., Tung C.L., Pan G.M., Tsai S.J. Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior. Neuropsychobiology 2003, 48:186-189.
38. Jiang X., Xu K., Hoberman J., Tian F., Marko A.J., Waheed J.F., et al. BDNF variation and mood disorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects. Neuropsychopharmacology 2005, 30:1353-1361.
39. Kaufman J., Yang B.Z., Douglas-Palumberi H., Grasso D., Lipschitz D., Houshyar S., et al. Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biol Psychiatry 2006, 59:673-680.
40. Kim B., Kim C.Y., Hong J.P., Kim S.Y., Lee C., Joo Y.H. Brain-derived neurotrophic factor Val/Met polymorphism and bipolar disorder. Association of the Metallele with suicidal behavior of bipolar patients. Neuropsychobiology 2008, 58:97-103.
41. Kim J.M., Stewart R., Kim S.W., Yang S.J., Shin I.S., Kim Y.H., et al. Interactions between life stressors and susceptibility genes (5-HTTLPR and BDNF) on depression in Korean elders. Biol Psychiatry 2007, 62:423-428.
42. Kim J.S., Kaye J., Wright L.K. Moderating and mediating effects in causal models. Issues Ment Health Nurs 2001, 22:63-75.
43. Knable M.B., Barci B.M., Webster M.J., Meador-Woodruff J., Torrey E.F. Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium. Mol Psychiatry 2004, 9:609-620.
44. Kunugi H., Iijima Y., Tatsumi M., Yoshida M., Hashimoto R., Kato T., et al. No association between the Val66Met polymorphism of the brain-derived neurotrophic factor gene and bipolar disorder in a Japanese population: a multicenter study. Biol Psychiatry 2004, 56:376-378.
45. Lang U.E., Hellweg R., Gallinat J. BDNF serum concentrations in healthy volunteers are associated with depression-related personality traits. Neuropsychopharmacology 2004, 29:795-798.
46. Lapalme M., Hodgins S., LaRoche C. Children of parents with bipolar disorder: a metaanalysis of risk for mental disorders. Can J Psychiatry 1997, 42:623-631.
47. Lin P.Y. State-dependent decrease in levels of brain-derived neurotrophic factor in bipolar disorder: a meta-analytic study. Neurosci Lett 2009, 466:139-143.
48. Müller D.J., de Luca V., Sicard T., King N., Strauss J., Kennedy J.L. Brain-derived neurotrophic factor (BDNF) gene and rapid-cycling bipolar disorder: family-based association study. Br J Psychiatry 2006, 189:317-323.
49. March J.S., Parker J.D., Sullivan K., Stallings P., Conners C.K. The Multidimensional Anxiety Scale for Children (MASC): factor structure, reliability, and validity. JAm Acad Child Adolesc Psychiatry 1997, 36:554-565.
50. McEwen B.S. From molecules to mind. Stress, individual differences, and the social environment. Ann N Y Acad Sci 2001, 935:42-49.
51. McTeague L.M., Lang P.J. The anxiety spectrum and the reflex physiology of defense: from circumscribed fear to broad distress. Depress Anxiety 2012, 29:264-281.
52. Montag C., Basten U., Stelzel C., Fiebach C.J., Reuter M. The BDNF Val66Met polymorphism and anxiety: support for animal knock-in studies from a genetic association study in humans. Psychiatry Res 2010, 179:86-90.
53. Montag C., Weber B., Fliessbach K., Elger C., Reuter M. The BDNF Val66Met polymorphism impacts parahippocampal and amygdala volume in healthy humans: incremental support for a genetic risk factor for depression. Psychol Med 2009, 39:1831-1839.
54. Nakata K., Ujike H., Sakai A., Uchida N., Nomura A., Imamura T., et al. Association study of the brain-derived neurotrophic factor (BDNF) gene with bipolar disorder. Neurosci Lett 2003, 337:17-20.
55. Nemoto K., Ohnishi T., Mori T., Moriguchi Y., Hashimoto R., Asada T., et al. The Val66Met polymorphism of the brain-derived neurotrophic factor gene affects age-related brain morphology. Neurosci Lett 2006, 397:25-29.
56. Neves-Pereira M., Mundo E., Muglia P., King N., Macciardi F., Kennedy J.L. The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am J Hum Genet 2002, 71:651-655.
57. Olson D. FACES IV and the Circumplex Model: validation study. JMarital Fam Ther 2011, 37:64-80.
58. Ostiguy C.S., Ellenbogen M.A., Linnen A.M., Walker E.F., Hammen C., Hodgins S. Chronic stress and stressful life events in the offspring of parents with bipolar disorder. JAffect Disord 2009, 114:74-84.
59. Ostiguy C.S., Ellenbogen M.A., Walker C.D., Walker E.F., Hodgins S. Sensitivity to stress among the offspring of parents with bipolar disorder: a study of daytime cortisol levels. Psychol Med 2011, 41:2447-2457.
60. Oswald P., Del-Favero J., Massat I., Souery D., Claes S., Van Broeckhoven C., et al. Non-replication of the brain-derived neurotrophic factor (BDNF) association in bipolar affective disorder: a Belgian patient-control study. Am J Med Genet B Neuropsychiatr Genet 2004, 129B:34-35.
61. Poznanski E.O., Freeman L.N., Mokros H.B. Children's depression rating scale-revised (September 1984). Psychopharmacol Bull 1985, 21:979-989.
62. Rakofsky J.J., Ressler K.J., Dunlop B.W. BDNF function as a potential mediator of bipolar disorder and post-traumatic stress disorder comorbidity. Mol Psychiatry 2012, 17:22-35.
63. Rasmusson A.M., Shi L., Duman R. Downregulation of BDNF mRNA in the hippocampal dentate gyrus after re-exposure to cues previously associated with footshock. Neuropsychopharmacology 2002, 27:133-142.
64. Romero S., Delbello M.P., Soutullo C.A., Stanford K., Strakowski S.M. Family environment in families with versus families without parental bipolar disorder: a preliminary comparison study. Bipolar Disord 2005, 7:617-622.
65. Roth T.L., Lubin F.D., Funk A.J., Sweatt J.D. Lasting epigenetic influence of early-life adversity on the BDNF gene. Biol Psychiatry 2009, 65:760-769.
66. Russo-Neustadt A. Brain-derived neurotrophic factor, behavior, and new directions for the treatment of mental disorders. Semin Clin Neuropsychiatry 2003, 8:109-118.
67. Shimizu E., Hashimoto K., Koizumi H., Kobayashi K., Itoh K., Mitsumori M., et al. No association of the brain-derived neurotrophic factor (BDNF) gene polymorphisms with panic disorder. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:708-712.
68. Singh M.K., DelBello M.P., Stanford K.E., Soutullo C., McDonough-Ryan P., McElroy S.L., et al. Psychopathology in children of bipolar parents. JAffect Disord 2007, 102:131-136.
69. Skibinska M., Hauser J., Czerski P.M., Leszczynska-Rodziewicz A., Kosmowska M., Kapelski P., et al. Association analysis of brain-derived neurotrophic factor (BDNF) gene Val66Met polymorphism in schizophrenia and bipolar affective disorder. World J Biol Psychiatry 2004, 5:215-220.
70. Sklar P., Gabriel S.B., McInnis M.G., Bennett P., Lim Y.M., Tsan G., et al. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol Psychiatry 2002, 7:579-593.
71. Soliman F., Glatt C.E., Bath K.G., Levita L., Jones R.M., Pattwell S.S., et al. Agenetic variant BDNF polymorphism alters extinction learning in both mouse and human. Science 2010, 327:863-866.
72. Strauss J., Barr C.L., George C.J., Devlin B., Vetró A., Kiss E., et al. Brain-derived neurotrophic factor variants are associated with childhood-onset mood disorder: confirmation in a Hungarian sample. Mol Psychiatry 2005, 10:861-867.
73. Suliman S., Hemmings S.M., Seedat S. Brain-Derived Neurotrophic Factor (BDNF) protein levels in anxiety disorders: systematic review and meta-regression analysis. Front Integr Neurosci 2013, 7:55.
74. Surtees P.G., Wainwright N.W., Willis-Owen S.A., Sandhu M.S., Luben R., Day N.E., et al. No association between the BDNF Val66Met polymorphism and mood status in a non-clinical community sample of 7389 older adults. JPsychiatr Res 2007, 41:404-409.
75. Tang J., Xiao L., Shu C., Wang G., Liu Z., Wang X., et al. Association of the brain-derived neurotrophic factor gene and bipolar disorder with early age of onset in mainland China. Neurosci Lett 2008, 433:98-102.
76. Thienemann M., Shaw R.J., Steiner H. Defense style and family environment. Child Psychiatry Hum Dev 1998, 28:189-198.
77. Tochigi M., Otowa T., Suga M., Rogers M., Minato T., Yamasue H., et al. No evidence for an association between the BDNF Val66Met polymorphism and schizophrenia or personality traits. Schizophr Res 2006, 87:45-47.
78. van Gastel W., Ferdinand R.F. Screening capacity of the Multidimensional Anxiety Scale for Children (MASC) for DSM-IV anxiety disorders. Depress Anxiety 2008, 25:1046-1052.
79. Vincze I., Perroud N., Buresi C., Baud P., Bellivier F., Etain B., et al. Association between brain-derived neurotrophic factor gene and a severe form of bipolar disorder, but no interaction with the serotonin transporter gene. Bipolar Disord 2008, 10:580-587.
80. Wendland J.R., Kruse M.R., Cromer K.R., Murphy D.L. Alarge case-control study of common functional SLC6A4 and BDNF variants in obsessive-compulsive disorder. Neuropsychopharmacology 2007, 32:2543-2551.
81. Young R.C., Biggs J.T., Ziegler V.E., Meyer D.A. Arating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978, 133:429-435.
82. Zhang H., Ozbay F., Lappalainen J., Kranzler H.R., van Dyck C.H., Charney D.S., et al. Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer's disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence. Am J Med Genet B Neuropsychiatr Genet 2006, 141B:387-393.